Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Buildings (2016 - 2017)

Immucell's Buildings history spans 7 years, with the latest figure at $5.4 million for Q3 2017.

  • For Q3 2017, Buildings rose 7.16% year-over-year to $5.4 million; the TTM value through Sep 2017 reached $5.4 million, up 7.16%, while the annual FY2016 figure was $5.0 million, 6.81% up from the prior year.
  • Buildings reached $5.4 million in Q3 2017 per ICCC's latest filing, roughly flat from $5.4 million in the prior quarter.
  • In the past five years, Buildings ranged from a high of $5.4 million in Q3 2017 to a low of $2.8 million in Q1 2013.
  • Average Buildings over 5 years is $4.1 million, with a median of $4.4 million recorded in 2015.
  • Peak YoY movement for Buildings: grew 1.01% in 2014, then surged 58.8% in 2015.
  • A 5-year view of Buildings shows it stood at $2.9 million in 2013, then rose by 1.01% to $3.0 million in 2014, then soared by 58.8% to $4.7 million in 2015, then rose by 6.81% to $5.0 million in 2016, then increased by 6.95% to $5.4 million in 2017.
  • Per Business Quant, the three most recent readings for ICCC's Buildings are $5.4 million (Q3 2017), $5.4 million (Q2 2017), and $5.4 million (Q1 2017).